2024
Understanding Use of E-cigarettes for Smoking Cessation Among a Sample of U.S. Adults
Sharma A, Morean M, Krishnan-Sarin S, O’Malley S, Bold K. Understanding Use of E-cigarettes for Smoking Cessation Among a Sample of U.S. Adults. Nicotine & Tobacco Research 2024, 27: 926-931. PMID: 39475073, PMCID: PMC12012231, DOI: 10.1093/ntr/ntae251.Peer-Reviewed Original ResearchQuit smokingNicotine replacement treatmentSmoking cessation aidE-cigarettesSmoking cessationCessation aidsSmoking cigarettesCessation attemptsSample of US adultsMajority of participantsSmoking cessation attemptsE-cigarette useComponents of e-cigarettesTime of surveyCessation supportUS adultsRegular cigarette smokingSmoking abstinenceRelapse rateNicotine patchSmokingReplacement treatmentNicotine-freeCigarette smokingOnline survey
2023
Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial
McKee S, Lawrence D, Saccone P, McRae T, Anthenelli R. Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial. Drug And Alcohol Dependence Reports 2023, 8: 100177. PMID: 37520849, PMCID: PMC10372180, DOI: 10.1016/j.dadr.2023.100177.Peer-Reviewed Original ResearchNeuropsychiatric adverse eventsCessation outcomesContinuous abstinenceAdverse eventsPsychiatric cohortPsychiatric statusLower oddsEfficacy of vareniclineSmoking cessation medicationsPoint prevalence abstinenceHigher baseline levelsSex effectsLogistic regression modelsEAGLES trialCessation medicationsBaseline characteristicsSmoking historyMedication useNicotine patchPoint prevalenceStudy treatmentBaseline variablesBaseline cigarettesAbstinence outcomesSignificant interaction
2021
Development and usability of a Spanish/English smoking cessation website: lessons learned
Bond M, Bunge E, Leykin Y, Barrera A, Wickham R, Barlow M, Reyes S, Pineda B, Ceja A, Cano M, Muñoz R. Development and usability of a Spanish/English smoking cessation website: lessons learned. MHealth 2021, 7: 30-30. PMID: 33898599, PMCID: PMC8063005, DOI: 10.21037/mhealth-19-255.Peer-Reviewed Original ResearchOnline interventionCompletion of follow-up assessmentsLow-income smokersSmoking cessation websiteIncreased engagementFollow-up rateFollow-up assessmentIntervention elementsMeasures of engagementInternet interventionsCessation websiteStudy registrationInterventionNicotine patchSmokersWeb appEngagementTracking toolAppsWebsitesSmokingCigaretteEvaluate modificationsCompletionLook-and-feel
2020
A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial
Rojewski AM, Fucito LM, Baker NL, Krishnan-Sarin S, Carpenter MJ, Bernstein SL, Toll BA. A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial. Nicotine & Tobacco Research 2020, 23: 1064-1067. PMID: 33340400, PMCID: PMC8248947, DOI: 10.1093/ntr/ntaa266.Peer-Reviewed Original ResearchConceptsDay of surgeryCancer surgeryAbstinence ratesContingency management interventionCM patientsCM interventionSeven-day point prevalence abstinence ratesCM groupSelf-reported smoking abstinencePoint prevalence abstinence ratesTobacco treatment programEnd of treatmentIncentives contingentMonetary incentives contingentBreath carbon monoxideCO breath testMultisite pilot studyOperable cancerStandard careNicotine patchCancer patientsSmoking abstinenceSurgical proceduresBreath testPatients
2019
Prenatal nicotine sex-dependently alters adolescent dopamine system development
Dwyer JB, Cardenas A, Franke RM, Chen Y, Bai Y, Belluzzi JD, Lotfipour S, Leslie FM. Prenatal nicotine sex-dependently alters adolescent dopamine system development. Translational Psychiatry 2019, 9: 304. PMID: 31740669, PMCID: PMC6861272, DOI: 10.1038/s41398-019-0640-1.Peer-Reviewed Original ResearchConceptsDopamine systemStriatal dopamine transporter bindingNorepinephrine transporterCocaine-induced locomotor activityGestational day 4Role of D2Postnatal day 32Dopamine transporter bindingCatechol-O-methyl transferaseElectronic nicotine delivery systemsCocaine-induced behaviorsPublic health initiativesSex-independent effectsNicotine delivery systemsG protein couplingNaïve damsMaternal smokingNicotine patchClinical deficitsDopamine turnoverOsmotic minipumpsPlasma levelsNeurobehavioral deficitsPregnant damsReceptor expressionA Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease
Rajaee S, Holder T, Indes JE, Muhs B, Sarac T, Sumpio B, Toll BA, Ochoa Chaar CI. A Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease. Annals Of Vascular Surgery 2019, 61: 91-99.e3. PMID: 31449932, DOI: 10.1016/j.avsg.2019.06.017.Peer-Reviewed Original ResearchMeSH KeywordsAneurysmCardiovascular AgentsCholinergic AgentsConnecticutEndovascular ProceduresFemaleHumansMaleMiddle AgedNicotinePatient Education as TopicPeripheral Arterial DiseasePilot ProjectsRisk FactorsRisk Reduction BehaviorSmokersSmokingSmoking CessationTime FactorsTobacco Use Cessation DevicesTransdermal PatchTreatment OutcomeVascular Surgical ProceduresConceptsSmoking cessation interventionIntervention groupSurgery providersPrimary outcomeCessation interventionsExact testBrief smoking cessation counselingCurrent smoking cessation practicesCarbon monoxide breath testingSmoking cessation counselingSmoking cessation practicesVascular surgery serviceSmoking cessation counseling sessionsTertiary care centerFree nicotine patchesSmoking cessation programOpen surgical proceduresOutpatient smoking cessation programFisher's exact testCessation counselingVascular complicationsStandard careNicotine patchNicotine replacementVascular patients
2017
Gender differences in the real-world effectiveness of smoking cessation medications: Findings from the 2010–2011 Tobacco Use Supplement to the Current Population Survey
Smith PH, Zhang J, Weinberger AH, Mazure CM, McKee SA. Gender differences in the real-world effectiveness of smoking cessation medications: Findings from the 2010–2011 Tobacco Use Supplement to the Current Population Survey. Drug And Alcohol Dependence 2017, 178: 485-491. PMID: 28715776, PMCID: PMC6779031, DOI: 10.1016/j.drugalcdep.2017.05.046.Peer-Reviewed Original ResearchConceptsTransdermal nicotine patchUnassisted quit attemptsClinical trial dataTobacco Use SupplementQuit attemptsTrial dataClinical trial findingsReal-world effectivenessSample of smokersGender differencesRelevant gender differencesCessation optionsCessation medicationsCessation pharmacotherapyNicotine patchMedication interactionsSmoking cessationPotential confoundersTrial findingsVareniclineComparative effectivenessPropensity scoreCross-sectional dataWomenMedications
2015
Reduction of Aggressive Episodes After Repeated Transdermal Nicotine Administration in a Hospitalized Adolescent with Autism Spectrum Disorder
Van Schalkwyk GI, Lewis AS, Qayyum Z, Koslosky K, Picciotto MR, Volkmar FR. Reduction of Aggressive Episodes After Repeated Transdermal Nicotine Administration in a Hospitalized Adolescent with Autism Spectrum Disorder. Journal Of Autism And Developmental Disorders 2015, 45: 3061-3066. PMID: 25982311, PMCID: PMC4755349, DOI: 10.1007/s10803-015-2471-0.Peer-Reviewed Original ResearchConceptsTransdermal nicotineNicotine administrationAutism spectrum disorderTransdermal nicotine administrationAdjunctive medicationsCurrent pharmacotherapyNicotine patchCholinergic dysfunctionEmergency medicationPreclinical studiesSpectrum disorderAnimal studiesAcetylcholinergic neurotransmissionNeuropsychiatric conditionsAggressive episodesMajor causeNicotineASD pathophysiologyMedicationsMorbidityFurther studiesAggression-related behaviorsAdministrationDisordersAdolescentsSuccessful Tobacco Dependence Treatment in Low-Income Emergency Department Patients: A Randomized Trial
Bernstein SL, D’Onofrio G, Rosner J, O’Malley S, Makuch R, Busch S, Pantalon MV, Toll B. Successful Tobacco Dependence Treatment in Low-Income Emergency Department Patients: A Randomized Trial. Annals Of Emergency Medicine 2015, 66: 140-147. PMID: 25920384, PMCID: PMC4819432, DOI: 10.1016/j.annemergmed.2015.03.030.Peer-Reviewed Original ResearchConceptsEmergency department patientsDepartment patientsUS EDsTobacco abstinence ratesGroup of smokersTobacco dependence treatmentMultivariable logistic modelingState Smokers' QuitlineLow incomeED smokersFaxed referralsQuitline referralQuitline useSecondary endpointsEligible subjectsPrimary outcomeIntervention armMedicaid insuranceNicotine patchNicotine replacementAbstinence ratesBooster callsIntervention subjectsControl armControl subjectsGender Differences in Medication Use and Cigarette Smoking Cessation: Results From the International Tobacco Control Four Country Survey
Smith PH, Kasza KA, Hyland A, Fong GT, Borland R, Brady K, Carpenter MJ, Hartwell K, Cummings KM, McKee SA. Gender Differences in Medication Use and Cigarette Smoking Cessation: Results From the International Tobacco Control Four Country Survey. Nicotine & Tobacco Research 2015, 17: 463-472. PMID: 25762757, PMCID: PMC4402353, DOI: 10.1093/ntr/ntu212.Peer-Reviewed Original ResearchConceptsMedication useInternational Tobacco Control Four Country SurveySmoking cessationFour Country SurveyQuit attemptsCessation medication useCigarette smoking cessationGender differencesAdjusted modelingQuit attemptersNicotine patchSuccessful quittingSubsample of smokersAdult smokersLower oddsCountry SurveyWomenSelf-selected useCessationSmokersSCM useMenWaves 2006Survey wavesVarenicline
2014
Sex Differences in the Brain's Dopamine Signature of Cigarette Smoking
Cosgrove KP, Wang S, Kim SJ, McGovern E, Nabulsi N, Gao H, Labaree D, Tagare HD, Sullivan JM, Morris ED. Sex Differences in the Brain's Dopamine Signature of Cigarette Smoking. Journal Of Neuroscience 2014, 34: 16851-16855. PMID: 25505336, PMCID: PMC4261105, DOI: 10.1523/jneurosci.3661-14.2014.Peer-Reviewed Original ResearchConceptsCigarette smokingVentral striatumCigarette smoking differsEffect of smokingEarly PET studiesMesolimbic dopamine systemRight ventral striatumSex differencesDopaminergic eventsMale smokersNicotine patchCessation treatmentFemale smokersDorsal putamenDopaminergic responseBrain scanningSmoking differsDrug effectsDopamine systemSmokingNeurotransmitter releasePublic health dangerPET studiesCue reactivityWomenConsideration of Sex in Clinical Trials of Transdermal Nicotine Patch: A Systematic Review
Weinberger AH, Smith PH, Kaufman M, McKee SA. Consideration of Sex in Clinical Trials of Transdermal Nicotine Patch: A Systematic Review. Experimental And Clinical Psychopharmacology 2014, 22: 373-383. PMID: 25133506, PMCID: PMC4180800, DOI: 10.1037/a0037692.Peer-Reviewed Original ResearchConceptsTransdermal nicotine patchNicotine patchCessation outcomesClinical trialsSmoking cessationSmoking cessation treatmentMenstrual cycle phaseCessation treatmentSex-related variablesInclusion criteriaMEDLINE searchSmoking treatmentSide effectsBetter outcomesTreatment efficacyConsideration of sexSystematic reviewPotential articlesInclusion of sexSkin irritationMore womenTrialsOutcomesSexWomenSmokers’ Treatment Expectancies Predict Smoking Cessation Success
Fucito LM, Toll BA, Roos CR, King AC. Smokers’ Treatment Expectancies Predict Smoking Cessation Success. The Journal Of Smoking Cessation 2014, 11: 143-149. PMID: 27594921, PMCID: PMC5006744, DOI: 10.1017/jsc.2014.17.Peer-Reviewed Original ResearchTreatment expectanciesQuit ratesPlacebo-controlled trialSmoking cessation successBetter treatment responseSmoking cessation aidSmoking cessation outcomesHigher quit ratesLower quit ratesNaltrexone groupPlacebo groupQuit dateCessation treatmentNicotine patchCessation aidCessation successCigarette smokersParticular medicationCessation outcomesTreatment responseBehavioral counselingMedication experienceTreatment assignmentFirst monthSmokersAddressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Bars MP, Forray A, Rojewski AM, Shiffman S, Selby P, West R, Foulds J, Toll BA, Networks W. Addressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine & Tobacco Research 2014, 16: 909-914. PMID: 24919399, PMCID: PMC6281057, DOI: 10.1093/ntr/ntu087.Peer-Reviewed Original ResearchConceptsQuit attemptsQuit dateSmoking reductionEffective smoking cessation interventionsSubstantial public health burdenAid smoking cessationNicotine patch useSmoking cessation interventionPublic health burdenShort-acting formsNRT formulationsNRT medicationsRecalcitrant smokersNicotine patchCessation interventionsCigarette smokingSmoking cessationHealth burdenProvider consultationTobacco useDrug AdministrationRelapse preventionSmokersLabeling changesMonths
2013
A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self‐administration
Udo T, Harrison EL, Shi J, Tetrault J, McKee SA. A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self‐administration. American Journal On Addictions 2013, 22: 590-597. PMID: 24131167, PMCID: PMC3934424, DOI: 10.1111/j.1521-0391.2013.12014.x.Peer-Reviewed Original ResearchConceptsSelf-administration periodNicotine nasal sprayHeavy drinking smokersNasal sprayNicotine patchAlcohol responsesPriming drinkSerum nicotine levelsPlacebo-controlled studyNicotine replacement therapySubjective alcohol responsesPositive subjective responsesNumber of drinksPlacebo administrationReplacement therapyPriming doseSmoking relapseAlcohol consumptionPlacebo conditionPatch applicationNicotine levelsClinical settingPilot studySmokersSubjective responses
2012
Rapid Nicotine Clearance is Associated with Greater Reward and Heart Rate Increases from Intravenous Nicotine
Sofuoglu M, Herman AI, Nadim H, Jatlow P. Rapid Nicotine Clearance is Associated with Greater Reward and Heart Rate Increases from Intravenous Nicotine. Neuropsychopharmacology 2012, 37: 1509-1516. PMID: 22334123, PMCID: PMC3327855, DOI: 10.1038/npp.2011.336.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAnalysis of VarianceCarbon MonoxideChi-Square DistributionChromatography, High Pressure LiquidCotinineDose-Response Relationship, DrugHeart RateHumansHydrocortisoneInjections, IntravenousMaleMiddle AgedNicotineNicotinic AgonistsSingle-Blind MethodSubstance Withdrawal SyndromeTandem Mass SpectrometryTime FactorsYoung AdultConceptsHigher nicotine metabolite ratioNicotine metabolite ratioHeart rate increaseCessation treatmentNicotine clearanceOvernight abstinenceGood drug effectBlood pressure measuresDiastolic blood pressure measuresEffects of nicotinePoor treatment responseNicotine dependence scoresTreatment-seeking smokersGreater heart rate increaseIntravenous dosesNicotine patchPoor outcomeNicotine rewardDrug likingFagerstrom TestTreatment outcomesIntravenous nicotineTreatment responseCigarette cravingHeart rate
2011
Effect of Night Smoking, Sleep Disturbance, and Their Co-Occurrence on Smoking Outcomes
Peters EN, Fucito LM, Novosad C, Toll BA, O'Malley SS. Effect of Night Smoking, Sleep Disturbance, and Their Co-Occurrence on Smoking Outcomes. Psychology Of Addictive Behaviors 2011, 25: 312-319. PMID: 21443301, PMCID: PMC3571661, DOI: 10.1037/a0023128.Peer-Reviewed Original ResearchConceptsSelf-reported sleep disturbanceCessation failureNight smokingSleep disturbancesSleep habitsGreater sleep disturbanceSmoking cessation treatmentSignificant sleep disturbanceSmoking outcomesPittsburgh Sleep Quality IndexCessation outcomesSleep Quality IndexRisk factorsCessation treatmentNicotine dependenceSingle itemHigh-risk groupPhysiological dependenceNicotine patchSleep cycleSmoking statusSmokersSmokingWeek 1Greater risk
2010
Nicotine dependence as a moderator of a quitline-based message framing intervention
Fucito LM, Latimer AE, Carlin-Menter S, Salovey P, Cummings KM, Makuch RW, Toll BA. Nicotine dependence as a moderator of a quitline-based message framing intervention. Drug And Alcohol Dependence 2010, 114: 229-232. PMID: 21036492, PMCID: PMC3044773, DOI: 10.1016/j.drugalcdep.2010.09.012.Peer-Reviewed Original ResearchConceptsMessage framing interventionsNicotine dependence scoresGain-framed messagesNicotine dependenceDependence scoresMore cigarettesPoint prevalence smoking abstinenceNew York State Smokers' QuitlineSmoking cessation treatmentHigh nicotine dependenceState Smokers' QuitlineBaseline total scoreHigher nicotine dependence scoresNicotine dependence levelHigher dependence scoresNicotine medicationsNicotine patchCessation treatmentDependent smokersSmoking abstinenceSmokersSmoking outcomesTotal scoreFraming interventionQuitlineExploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch
Epperson CN, Toll B, Wu R, Amin Z, Czarkowski KA, Jatlow P, Mazure CM, O’Malley S. Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. Drug And Alcohol Dependence 2010, 112: 1-8. PMID: 20561758, PMCID: PMC2946976, DOI: 10.1016/j.drugalcdep.2010.04.021.Peer-Reviewed Original ResearchConceptsPlacebo groupStudy completersNaltrexone doseClinical trialsContinuous abstinenceOral naltrexone treatmentNicotine patch therapyNicotine replacement therapyInteractive voice responseRandomized clinical trialsMenstrual cycle statusEffect of doseNaltrexone augmentationNaltrexone groupAdverse eventsNaltrexone treatmentNicotine patchPatch therapyReplacement therapyQuit dayWeek 1AbstinenceDoseWomenLess adherentLow-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial
Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O’Malley S. Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial. Drug And Alcohol Dependence 2010, 111: 200-206. PMID: 20542391, PMCID: PMC3771701, DOI: 10.1016/j.drugalcdep.2010.04.015.Peer-Reviewed Original ResearchConceptsWeight gainSmoking cessationPoint prevalence smoking abstinence ratePre-specified primary outcomesLow-dose naltrexoneOpen-label therapySmoking abstinence ratesPoint prevalence abstinenceReduced weight gainNaltrexone augmentationPlacebo groupNicotine replacementPrimary outcomeQuit dateAbstinence ratesLabel therapyNicotine patchBehavioral counselingNaltrexoneAbstinent participantsSmokersWeight concernsWeeksCessationLower rates
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply